Early research (Phase 1)Looking for participantsNCT07148050
What this trial is testing
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Who this might be right for
Solid Tumor (Excluding CNS)Liver Cell CarcinomaMalignant Rhabdoid Tumor+7 more
Seattle Children's Hospital 21